University of California, Berkeley - Extension
The Drug Development Process: An Intensive Seminar
Berkeley, USA
Course
DURATION
LANGUAGES
English
PACE
Full time
APPLICATION DEADLINE
EARLIEST START DATE
TUITION FEES
STUDY FORMAT
The seminar examines the complex, interrelated activities involved in bringing pharmaceutical discoveries to approval and market, while also incorporating biologics, diagnostics, and medical devices. Topics include the industry environment; drug discovery and pharmacology; chemistry, manufacturing and controls (CMC); toxicology; pharmacokinetics; program management; FDA inspections and compliance; biologics; assays and devices; clinical-trial design, conduct, monitoring, and statistics; pharmacogenomics; patents and intellectual property; postmarketing surveillance; and commercial development. Discussions are guided by experts with hands-on experience in pharmaceutical, biotechnology, and related companies. The course is designed for executives, disciplinary experts, nontechnical professionals, investors, and others interested in the biopharmaceutical industry.
The tentative Fall 2025 schedule is organized as a five-day intensive seminar. Monday covers introductions, regulatory affairs, biologics/biopharmaceuticals, CMC/pharmaceutical development, and toxicology. Tuesday covers drug discovery, drug metabolism and safety, pharmaco-omics, biomarkers, companion diagnostics, and a case study discussion. Wednesday covers drug delivery technologies, financial aspects of drug development, and QA/QC and compliance. Thursday covers postmarketing surveillance, patents/IP, pharmacokinetics, clinical development, and clinical-trial monitoring. Friday covers medical affairs and program management.


